For laboratory and research use only. Not for human consumption.  Sold exclusively to qualified researchers and licensed laboratories.

HOME  /  RESEARCH PEPTIDES  /  GLOW BLEND

GLOW peptide blend (BPC-157, GHK-Cu, TB-500): reagent reference

GLOW is a trade name for a lyophilised blend of three research peptides in one vial: BPC-157, GHK-Cu and TB-500. The supplier's documentation for the blend labels it as BPC-157 10 mg, GHK-Cu 50 mg and TB-500 10 mg per vial. It is a physical mixture, not a new compound, so it has no CAS number or PubChem record of its own: each component keeps its own identity, listed below.

This page is a reagent reference only: identity, storage, laboratory reconstitution and certificate status. It makes no statement about any use of the blend or its components.

Also searched as: GLOW, Glow peptide, GLOW blend, BPC-157 + GHK-Cu + TB-500

Research use only. Not a drug, food or cosmetic. GLOW blend is supplied strictly for laboratory and in-vitro research and is not for human consumption. It is not an approved therapeutic good in Australia, has not been evaluated or approved by the FDA or the TGA, and is not intended to diagnose, treat, cure or prevent any disease. Titan Peptides sells exclusively to qualified researchers and licensed laboratories.

Check the catalogue (account required) The catalogue, prices and checkout require a free account login.

Identity and structure

NameGLOW (peptide blend)
Composition as labelled by the supplierBPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg per vial
Component 1BPC-157: GEPPPGKPADDAGLV, C62H98N16O22, 1419.5 g/mol, CAS 137525-51-0, PubChem CID 9941957
Component 2GHK-Cu: Gly-His-Lys copper(II) complex, C14H23CuN6O4+, 402.92 g/mol (1:1 complex), CAS 89030-95-5, PubChem CID 71587328
Component 3TB-500: Ac-LKKTETQ, C38H68N10O14, 889.0 g/mol, CAS 885340-08-9, PubChem CID 62707662
CAS number of the blendNone: a mixture has no single CAS number
AppearanceLyophilised (freeze-dried) powder in a sealed vial. The copper(II) in GHK-Cu can give the powder and its solutions a blue tint.
Intended useLaboratory and research use only

Component formulas, molecular weights, CAS numbers and compound IDs are PubChem reference values. Quantities are as labelled by the supplier and have not been independently verified. Sources

Storage and handling

Store the sealed vial dry, dark and frozen at −20 °C or colder, and let it reach room temperature in a desiccator before opening.S1 A blend is only as stable as its least stable component: TB-500's C-terminal glutamine can deamidate in solution, and the copper complex changes species with pH. Keep reconstituted stock as frozen single-use aliquots and do not refreeze a thawed aliquot.

Reconstitution: laboratory procedure

Because three peptides share one solution, choose a solvent compatible with all of them: water or a near-neutral buffer, free of chelators such as EDTA that would strip copper from GHK-Cu.

  1. Work in a clean laminar-flow or biosafety cabinet using aseptic technique, with gloves and eye protection.
  2. Let the sealed vial reach room temperature in a desiccator before opening, so moisture does not condense on the powder.
  3. Tap or briefly centrifuge the vial so all of the powder sits at the bottom.
  4. Use the solvent your assay protocol specifies. Sterile water or a suitable buffer suits most short, charged peptides; a sequence that resists dissolving may need the small amount of dilute acetic acid or organic co-solvent described in standard peptide handling guides.S1
  5. Add the solvent slowly down the inside wall of the vial with a calibrated pipette, then swirl or roll gently until the solution is clear. Avoid vigorous shaking or vortexing, which can promote aggregation.
  6. If the assay needs a sterile solution, pass it through a 0.22 µm low-protein-binding filter.
  7. Label the stock with compound, solvent, date and batch number, split it into single-use aliquots, and freeze them at −20 °C or colder. Thaw one aliquot per experiment and discard what is left rather than refreezing it.

The concentration of a stock solution is set by the assay protocol, not by this page. Our guides to reconstituting peptides with bacteriostatic or sterile water and how to store peptides explain the reasoning behind each step.

Certificate of analysis

Purity: not published. Titan Peptides publishes a purity figure only once a certificate of analysis (COA) for the batch has been checked and its compound name, CAS number and sequence match the product. Until that check is complete, no purity figure is shown on this page or in the catalogue.

A COA is available to account holders on request. Our guide on how to read a peptide certificate of analysis explains what to check, and HPLC and mass spectrometry for peptide purity covers how the figures are measured.

Status in Australia

Schedule 4 (Poisons Standard).

In the Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, which commenced on 1 June 2026, BPC-157 is listed in Schedule 4 (prescription-only medicines) and in Appendix D, clause 5, the table of poisons that "must not be possessed by a person without authority".4

In the June 2026 Poisons Standard, TB-500 and thymosin beta 4 each have their own entry in Schedule 4 (prescription-only medicines), and each is also listed in Appendix D, clause 5, which covers poisons that "must not be possessed by a person without authority".4

The TGA's 13 April 2026 safety advisory names BPC-157, TB-500 and GHK-Cu as examples of unapproved peptide products and states that a "research use only" disclaimer does not make supply lawful.5 A blend containing them is not an approved therapeutic good in Australia. See research peptides and Australian law.

GLOW blend: quick answers

What is in the GLOW peptide blend?

GLOW is a trade name for a lyophilised mixture of three research peptides in one vial: BPC-157, GHK-Cu and TB-500. The supplier labels the vial as BPC-157 10 mg, GHK-Cu 50 mg and TB-500 10 mg. Each component keeps its own CAS number and PubChem record.

Does GLOW have a CAS number?

No. A CAS number identifies a single substance, and GLOW is a mixture. Use the component identities instead: BPC-157 is CAS 137525-51-0, GHK-Cu (prezatide copper) is CAS 89030-95-5 and TB-500 is CAS 885340-08-9.

How can each component of a blend be identified?

Liquid chromatography with mass spectrometry separates the components and confirms each by mass: about 1419.5 g/mol for BPC-157, 889.0 g/mol for TB-500 and 340.38 g/mol for the GHK peptide, which may appear with or without its copper. A certificate for a blend should report each component, not a single mass.

How should the GLOW blend be stored?

Sealed, dry and dark at −20 °C or colder. Warm the vial to room temperature in a desiccator before opening, reconstitute in a solvent compatible with all three components, and keep the solution as frozen single-use aliquots.

From the research library

Compound Profiles

BPC-157: Compound Profile, Structure and Regulation

A chemical profile of BPC-157: the 15-residue sequence and its identifiers, salt forms, how identity is checked in the laboratory, storage, and its place in the Australian Poisons Standard.

21 September 2026 · 3 min read
Compound Profiles

TB-500 and Thymosin Beta-4: Compound Profile and Identity

A chemical profile of TB-500, the N-acetylated LKKTETQ fragment of thymosin beta-4: identifiers, how the fragment and the full protein differ, where descriptions disagree, and how identity is checked.

21 September 2026 · 4 min read
Compound Profiles

GHK-Cu Copper Peptide: Compound Profile and Chemistry

A chemical profile of GHK-Cu, the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine: how the copper is bound, the 1:1 and 2:1 forms, the names in use, bench handling and regulation.

21 September 2026 · 3 min read

Peer-reviewed literature

Listed by title and journal for identification only. Titan Peptides does not summarise or rely on the findings of these papers.

  1. Cox HD, Miller GD, Eichner D. Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H. Drug Test Anal. 2017;9(10):1490-1498. PubMed 28035768
  2. Hureau C, Eury H, Guillot R, et al. X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes: influence on their redox properties. Chemistry. 2011;17(36):10151-60. PubMed 21780203
  3. Low TL, Hu SK, Goldstein AL. Complete amino acid sequence of bovine thymosin beta 4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations. Proc Natl Acad Sci U S A. 1981;78(2):1162-6. PubMed 6940133

Sources

  1. PubChem. BPC-157, CID 9941957. National Center for Biotechnology Information. Source
  2. PubChem. Prezatide copper (copper tripeptide-1), CID 71587328. National Center for Biotechnology Information. Source
  3. PubChem. TB-500 (Ac-LKKTETQ), CID 62707662. National Center for Biotechnology Information. Source
  4. Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 (Standard for the Uniform Scheduling of Medicines and Poisons No. 48), F2026L00633. Commenced 1 June 2026. Federal Register of Legislation. Source
  5. Therapeutic Goods Administration. Understanding your responsibilities when importing, compounding and supplying unapproved peptide products (safety advisory). Published 13 April 2026. Source
  1. S1. Bachem. Handling and storage guidelines for peptides (Peptide Guide, chapter 6). Source
  2. S2. Sigma-Aldrich (Merck). Handling and storage guidelines for peptides and proteins. Source
Research use only. Not a drug, food or cosmetic. GLOW blend is supplied strictly for laboratory and in-vitro research and is not for human consumption. It is not an approved therapeutic good in Australia, has not been evaluated or approved by the FDA or the TGA, and is not intended to diagnose, treat, cure or prevent any disease. Titan Peptides sells exclusively to qualified researchers and licensed laboratories.